Disagreement between patientâ and physicianâreported outcomes on symptomatic adverse events as poor prognosis in patients treated with firstâline cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
Ooki, Akira, Morita, Satoshi, Tsuji, Akihito, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, TaJournal:
Cancer Medicine
DOI:
10.1002/cam4.3564
Date:
November, 2020
File:
PDF, 716 KB
2020